Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Considerations for optimizing Wilson¿s disease patients¿ long-term follow-up
Gilberto Herrera-Quiñones; Angella María Dafieno; Yaroslau Compta; Xavier Forns; Zoe Mariño;
Gastroenterol Hepatol. 2022;45:146-54
Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease
Marlone Cunha-Silva; Luíza D. Torres; Mariana F. Fernandes; Tirzah de M. Lopes Secundo; Marina C.G. Moreira; Ademar Yamanaka; Leonardo T. Monici; Larissa B. Eloy da Costa; Daniel F. Mazo; Tiago Sevá-Pereira;
Gastroenterol Hepatol. 2022;45:579-84
Concordance between hepatic biopsy and the APRI index (Ast to Platelet Ratio Index) for the diagnosis of cirrhosis in patients with autoimmune liver disease
Carmen Yanette Suarez-Quintero; Oscar Patarroyo Henao; Oscar Muñoz-Velandia;
Gastroenterol Hepatol. 2021;44:465-71